Research Article
A Mini Library of Novel Triazolothiadiazepinylindole Analogues: Synthesis, Antioxidant and Antimicrobial Evaluations
Table 2
Zone of inhibition in mm at 25, 50, and 100 µg/mL concentrations.
| Compd name | Antibacterial activity | Antifungal activity | S. aureus | E. coli | K. pneumoniae | C. tropicalis | C. albicans | 25 | 50 | 100 | 25 | 50 | 100 | 25 | 50 | 100 | 25 | 50 | 100 | 25 | 50 | 100 |
| 3a | 13 | 17 | 20 | 15 | 20 | 22 | 16 | 22 | 25 | 14 | 18 | 20 | 13 | 15 | 18 | 3b | 14 | 16 | 20 | 16 | 19 | 24 | 15 | 21 | 24 | 15 | 17 | 21 | 14 | 17 | 19 | 3c | 15 | 15 | 19 | 14 | 21 | 25 | 14 | 23 | 26 | 13 | 16 | 20 | 15 | 16 | 20 | 3d | 11 | 12 | 17 | 12 | 15 | 16 | 09 | 14 | 15 | 10 | 12 | 15 | 10 | 12 | 14 | 3e | 10 | 13 | 15 | 11 | 16 | 17 | 08 | 15 | 18 | 09 | 11 | 14 | 09 | 11 | 12 | 3f | 09 | 12 | 16 | 09 | 14 | 16 | 09 | 13 | 14 | 09 | 12 | 13 | 09 | 10 | 10 | 3g | 02 | 06 | 08 | 05 | 07 | 08 | 05 | 07 | 09 | 02 | 04 | 06 | 03 | 04 | 05 | 3h | 03 | 04 | 09 | 03 | 05 | 07 | 04 | 08 | 10 | 01 | 03 | 05 | 03 | 06 | 09 | 3i | 05 | 07 | 08 | 04 | 06 | 08 | 03 | 06 | 08 | 03 | 04 | 06 | 05 | 06 | 08 | 3j | 14 | 18 | 21 | 18 | 18 | 23 | 15 | 21 | 23 | 15 | 18 | 21 | 13 | 15 | 17 | 3k | 13 | 19 | 20 | 17 | 20 | 22 | 17 | 23 | 24 | 16 | 19 | 21 | 15 | 17 | 18 | 3l | 12 | 18 | 21 | 16 | 19 | 25 | 16 | 22 | 26 | 12 | 15 | 21 | 13 | 16 | 19 | 3m | 10 | 10 | 15 | 10 | 12 | 15 | 09 | 15 | 16 | 10 | 12 | 15 | 09 | 11 | 12 | 3n | 08 | 11 | 14 | 08 | 13 | 14 | 10 | 13 | 18 | 09 | 11 | 14 | 09 | 09 | 11 | 3o | 08 | 10 | 14 | 09 | 14 | 16 | 09 | 13 | 19 | 08 | 10 | 12 | 10 | 10 | 12 | 3p | 03 | 04 | 09 | 04 | 05 | 08 | 06 | 08 | 12 | 04 | 06 | 08 | 03 | 05 | 07 | 3q | 03 | 05 | 07 | 03 | 05 | 08 | 05 | 09 | 11 | 03 | 05 | 07 | 05 | 06 | 08 | 3r | 04 | 06 | 08 | 06 | 08 | 09 | 04 | 08 | 10 | 02 | 05 | 06 | 03 | 06 | 07 | 3s | 10 | 10 | 15 | 10 | 12 | 15 | 09 | 14 | 15 | 10 | 12 | 14 | 11 | 12 | 13 | 3t | 09 | 11 | 13 | 11 | 14 | 17 | 10 | 15 | 18 | 08 | 11 | 15 | 09 | 10 | 12 | 3u | 08 | 11 | 14 | 08 | 13 | 14 | 10 | 13 | 14 | 09 | 13 | 13 | 08 | 12 | 14 | 3v | 09 | 09 | 16 | 10 | 12 | 15 | 11 | 12 | 17 | 10 | 12 | 15 | 09 | 13 | 15 | 3w | 08 | 10 | 14 | 09 | 14 | 16 | 09 | 12 | 15 | 09 | 11 | 16 | 10 | 11 | 12 | 3x | 09 | 12 | 12 | 09 | 11 | 14 | 08 | 14 | 16 | 08 | 10 | 17 | 09 | 10 | 12 | 3y | 04 | 06 | 09 | 05 | 08 | 10 | 05 | 09 | 10 | 05 | 09 | 10 | 04 | 05 | 06 | 3z | 05 | 05 | 08 | 04 | 09 | 11 | 04 | 10 | 12 | 04 | 08 | 11 | 04 | 04 | 05 |
| Std.1 | 15 | 19 | 22 | 18 | 21 | 25 | 17 | 23 | 27 | — | — | — | — | — | — | Std.2 | — | — | — | — | — | — | — | — | — | 15 | 19 | 22 | 16 | 19 | 21 |
|
|
Std.1: gentamycin, Std.2: fluconazole. The bold font refers to the compounds which have shown more potent antimicrobial activities.
|